Skip to main navigation Skip to search Skip to main content

A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes

  • Hae Kyung Yang
  • , Kyung Wan Min
  • , Sung Woo Park
  • , Choon Hee Chung
  • , Kyong Soo Park
  • , Sung Hee Choi
  • , Ki Ho Song
  • , Doo Man Kim
  • , Moon Kyu Lee
  • , Yeon Ah Sung
  • , Sei Hyun Baik
  • , In Joo Kim
  • , Bong Soo Cha
  • , Jeong Hyun Park
  • , Yu Bae Ahn
  • , In Kyu Lee
  • , Soon Jib Yoo
  • , Jaetaek Kim
  • , Ie Byung Park
  • , Tae Sun Park
    • Kun Ho Yoon

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science